From HTS to Phase I: The Institute for Therapeutics Discovery and Development at the University of Minnesota

Author(s): Peter I. Dosa , Gunda I. Georg , Vadim J. Gurvich , Jon E. Hawkinson , Michael A. Walters , Henry L. Wong .

Journal Name: Combinatorial Chemistry & High Throughput Screening

Volume 17 , Issue 3 , 2014

Become EABM
Become Reviewer

Abstract:

The high-throughput screening core at the University of Minnesota is part of the Institute for Therapeutics Discovery and Development (ITDD), a comprehensive drug discovery and development center. The Institute provides scientific services to both academic and business communities and supports translational medicine via collaborations and contractual work. The ITDD is well-known for its broad range of screening capabilities and offers extensive medicinal chemistry expertise along with GMP scale-up and pre-clinical pharmacology support.

Keywords: Drug development, drug discovery, good manufacturing practices (GMP), high throughput screening (HTS), medicinal chemistry, pharmacology, scale-up, translational science.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 3
Year: 2014
Page: [231 - 240]
Pages: 10
DOI: 10.2174/1386207317666140109122033
Price: $58

Article Metrics

PDF: 28